If I'm reading that first graph correctly, which is for the whole tested population, the averaged pain reduction for iPPS is only at best about 6% less than the placebo. So what I'm interpreting is that for some severe pain sufferers a more substantial reduction is found ( previous announcement) , but averaged out over the whole population tested it does not look to be too impressive. Or am I dead wrong?
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigms Supplementary Phase 2B Data
Ann: Paradigms Supplementary Phase 2B Data, page-4
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $129.3K | 520.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 59256 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 35769 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 59988 | 0.245 |
5 | 94868 | 0.240 |
4 | 45113 | 0.235 |
9 | 120349 | 0.230 |
9 | 99522 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 31178 | 6 |
0.255 | 44647 | 8 |
0.260 | 26415 | 3 |
0.265 | 34042 | 1 |
0.270 | 23333 | 3 |
Last trade - 15.18pm 11/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |